|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10135 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-PIK3 gamma |
| 克隆性 | |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human PIK3 gamma |
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 磷脂酰肌醇激酶PIK3-γ抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-PIK3 gamma
中文名稱 磷脂酰肌醇激酶PIK3-γ抗體品牌
別 名 PK3CG_HUMAN; PI 3 Kinase catalytic subunit gamma; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform; PI3-kinase subunit gamma; PI3K-gamma; PI3Kgamma; PtdIns-3-kinase subunit gamma; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma; PtdIns-3-kinase subunit p110-gamma; p110gamma; Phosphoinositide-3-kinase catalytic gamma polypeptide; Serine/threonine protein kinase PIK3CG; 1 phosphatidylinositol 3 kinase; p120-PI3K; p120 PI3K; 5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma; 5-bisphosphate 3-kinase catalytic subunit gamma isoform; p110 gamma; Phosphatidylinositol 3 kinase catalytic 110 kD gamma; Phosphatidylinositol 3 kinase gamma, p110 gamma; Phosphatidylinositol 3 kinase, catalytic, gamma polypeptide; Phosphatidylinositol 4 5 bisphosphate 3 kinase 110 kDa catalytic subunit gamma; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit gamma; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit gamma isoform; Phosphatidylinositol-4; Phosphoinositide 3 kinase catalytic gamma polypeptide; Phosphoinositide 3 kinase gamma catalytic subunit; PI3-kinase subunit gamma; PI3CG; PI3K; PIK3; Pik3cg; PtdIns-3-kinase subunit gamma; PtdIns-3-kinase subunit p110-gamma; Serine/threonine protein kinase PIK3CG.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶 G蛋白偶聯(lián)受體 G蛋白信號(hào)
蛋白分子量 predicted molecular weight: 121kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PIK3 gamma
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
磷脂酰肌醇激酶PIK3-γ抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 This gene encodes a protein that belongs to the pi3/pi4-kinase family of proteins. The gene product is an enzyme that phosphorylates phosphoinositides on the 3-hydroxyl group of the inositol ring. It is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In addition to its role in promoting assembly of adherens junctions, the protein is thought to play a pivotal role in the regulation of cytotoxicity in NK cells. The gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. [provided by RefSeq, Jul 2008].
Function : Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Links G-protein coupled receptor activation to PIP3 production. Involved in immune, inflammatory and allergic responses. Modulates leukocyte chemotaxis to inflammatory sites and in response to chemoattractant agents. May control leukocyte polarization and migration by regulating the spatial accumulation of PIP3 and by regulating the organization of F-actin formation and integrin-based adhesion at the leading edge. Controls motility of dendritic cells. Together with PIK3CD is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in T-lymphocyte migration. Regulates T-lymphocyte proliferation and cytokine production. Together with PIK3CD participates in T-lymphocyte development. Required for B-lymphocyte development and signaling. Together with PIK3CD participates in neutrophil respiratory burst. Together with PIK3CD is involved in neutrophil chemotaxis and extravasation. Together with PIK3CB promotes platelet aggregation and thrombosis. Regulates alpha-IIb/beta-3 integrins (ITGA2B/ ITGB3) adhesive function in platelets downstream of P2Y12 through a lipid kinase activity-independent mechanism. May have also a lipid kinase activity-dependent function in platelet aggregation. Involved in endothelial progenitor cell migration. Negative regulator of cardiac contractility. Modulates cardiac contractility by anchoring protein kinase A (PKA) and PDE3B activation, reducing cAMP levels. Regulates cardiac contractility also by promoting beta-adrenergic receptor internalization by binding to ADRBK1 and by non-muscle tropomyosin phosphorylation. Also has serine/threonine protein kinase activity: both lipid and protein kinase activities are required for beta-adrenergic receptor endocytosis. May also have a scaffolding role in modulating cardiac contractility. Contributes to cardiac hypertrophy under pathological stress. Through simultaneous binding of PDE3B to RAPGEF3 and PIK3R6 is assembled in a signaling complex in which the PI3K gamma complex is activated by RAPGEF3 and which is involved in angiogenesis.
Subunit : Heterodimer of a catalytic subunit PIK3CG and a PIK3R5 or PIK3R6 regulatory subunit. Interacts with ADRBK1 through the PIK helical domain. Interaction with ADRBK1 is required for targeting to agonist-occupied receptor. Interacts with PDE3B. Interacts with TPM2. Interacts with EPHA8; regulates integrin-mediated cell adhesion to substrate. Interacts with HRAS1; the interaction is required for membrane recruitment and beta-gamma G protein dimer-dependent activation of the PI3K gamma complex PIK3CG:PIK3R6 (By similarity).
Subcellular Location : Cytoplasm. Cell membrane.
Similarity : Belongs to the PI3/PI4-kinase family.
Contains 1 C2 PI3K-type domain.
Contains 1 PI3K-ABD domain.
Contains 1 PI3K-RBD domain.
Contains 1 PI3K/PI4K domain.
Contains 1 PIK helical domain.
Database links : UniProtKB/Swiss-Prot: P48736.3
抗體的鑒定：
1）磷脂酰肌醇激酶PIK3-γ抗體品牌 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
TSGF ELISA Kit 大鼠特異生長(zhǎng)因子/相關(guān)因子Multi-class antibodies規(guī)格： 48T
Anti-TSARG4 生精細(xì)胞凋亡相關(guān)基因4抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh GHDC GHDC蛋白抗體 規(guī)格 0.2ml
TSGF(Mouse Tumor Specific Growth Facter/tumor supplied group of factor) ELISA KIT 小鼠特異生長(zhǎng)因子/相關(guān)因子 96T
NDRG4 英文名稱： 基因NDRG4抗體 0.2ml
ATPase Na+/ K+ beta 2 英文名稱： ATP酶通道蛋白抗體 0.1ml
Anti-TSARG4 生精細(xì)胞凋亡相關(guān)基因4抗體Multi-class antibodies規(guī)格： 0.2ml
TP I (topoisomerase I ) 拓普西異構(gòu)酶Ⅰ抗原Multi-class antibodies規(guī)格： 0.5mg
Anti-phosphor-Caldesmon(Ser789) 磷酸化鈣介質(zhì)素抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh PDHA1/PDH-E1α 酸脫氫酶α1抗體 規(guī)格 0.2ml
Bax 濃縮液 0.1ml 進(jìn)口分裝
TRF1 英文名稱： 端粒體復(fù)制結(jié)合因子1抗體 0.1ml
C1orf33 英文名稱： 1號(hào)染色體開(kāi)放閱讀框33抗體 0.2ml
Anti-phosphor-Caldesmon(Ser789) 磷酸化鈣介質(zhì)素抗體Multi-class antibodies規(guī)格： 0.2ml
Anti-Lingo-1/FITC 熒光素標(biāo)記Nogo受體作用蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Astrocyte/FITC 熒光素標(biāo)記兔抗人星形膠質(zhì)細(xì)胞抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh ADRB2 能受體β2抗體(β2-AR ) 規(guī)格 0.1ml
Rabbit Anti-Goat IgM/Gold 膠體金標(biāo)記的兔抗羊IgM 2ml
GODZ 英文名稱： 棕櫚酰轉(zhuǎn)移酶GODZ抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-dog IgG/APC APC標(biāo)記的兔抗狗IgG 規(guī)格 0.1ml
Anti-Astrocyte/FITC 熒光素標(biāo)記兔抗人星形膠質(zhì)細(xì)胞抗體IgGMulti-class antibodies規(guī)格： 0.2ml
人骨髓間充質(zhì)干細(xì)胞(hMSCs)
NCI-H524 人小細(xì)胞
FST Others Human 人 FST / Follistatin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
mCF, 小鼠成纖維細(xì)胞
293來(lái)源病毒包裝細(xì)胞;ΦA(chǔ)-GP
人;HFL1 人淋巴成纖維細(xì)胞完全培養(yǎng)基 100mL
CL-0216SMMC-7721(人細(xì)胞)5×106cells/瓶×2
MST4 Others Human 人 MST4 桿狀病毒-昆蟲(chóng)細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人真皮成纖維細(xì)胞-胎兒cDNAHDF-f cDNA
5637細(xì)胞，人細(xì)胞 人胚,CCC-HPF-1細(xì)胞 骨骼肌細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
狗腎惡性癥細(xì)胞;DH82
THPO Others Human 人 Thrombopoietin / THPO / TPO / TPO 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
磷脂酰肌醇激酶PIK3-γ抗體品牌 人骨髓間充質(zhì)干細(xì)胞(hMSCs)
NCI-H524 人小細(xì)胞
FST Others Human 人 FST / Follistatin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
mCF, 小鼠成纖維細(xì)胞
293來(lái)源病毒包裝細(xì)胞;ΦA(chǔ)-GP
人;HFL1 人淋巴成纖維細(xì)胞完全培養(yǎng)基 100mL
|
|
|
|
|
